"We must not be left behind with new prostate cancer treatments."

PHEN president and founder Thomas A. Farrington talks about his prostate cancer journey and the importance of African American men participating in clinical trials.

Information



Understanding the possible benefits for patients when participating in a clinical trial.


Clinical trials offer important and unique benefits to patients.

Information

Dr. Jacques Carter Presents Clinical Trials 101 for Patients

Dr. Carter's brief video presentations provide basic information for patients to better understand clinical trials.

Information





What Are Clinical Trials?


Information that all patients need to know when considering enrolling into a clinical trial.

Information

EMBARK clinical trial summary

For patients with a rising PSA after being treated with surgery, radiation or both.

Information

The TRUMPET Registry

For men whose prostate cancer has grown or spread despite use of hormonal treatments to lower their PSA; Known as castration-resistant prostate cancer.

Information

ENACT clinical trial summary

For patients considering active surveillance or currently undergoing active surveillance.

Information

ATLAS clinical trial summary

For patients diagnosed with high-risk, localized or locally advanced prostate cancer as determined by a high PSA and/or Gleason Score and cancer stage.

Information

TITAN Clinical Trial Summary

The TITAN trial is for patients with prostate cancer that has spread to their bones but androgen deprivation (hormone) therapy is still effective in keeping the PSA low. This is called Metastatic Hormone-sensitive Prostate Cancer (mHSPC).

Information



A listing of all the prostate cancer clinical trials listed on clinicaltrials.gov that are currently recruiting patients.

Information










PHEN,Inc. © 2017 All rights reserved